跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Saphvas-20 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Saphvas-20
Approved
STANDARD
Saphvas-20
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f15cce50bf39f34f
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
f15cce50bf39f34f
Drug Approval Philippines Name
Saphvas-20
Product Name
Saphvas-20
Registration Number
DRP-4403
Brand Name
Saphvas-20
Generic Name
Simvastatin
Dosage Form
Film-Coated Tablet
Dosage Strength
20 mg
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Distributor
Nelpa Lifesciences, Inc.
Issuance Date
29 May 2023
Expiry Date
02 May 2028
Pharmacologic Category
HMG-CoA Reductase Inhibitor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f15cce50bf39f34f
Type
Standard
Back to Philippines FDA Approvals